Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.370
+0.020 (1.48%)
At close: Jul 11, 2025, 4:00 PM
1.380
+0.010 (0.73%)
After-hours: Jul 11, 2025, 6:31 PM EDT

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
931217498278-
Upgrade
Market Cap Growth
8.38%62.54%-23.65%-64.90%--
Upgrade
Enterprise Value
-105-97-33-32108-
Upgrade
Last Close Price
1.371.802.703.6710.46-
Upgrade
Debt / Equity Ratio
0.000.000.000.00--
Upgrade
Quick Ratio
14.1330.8338.5721.3523.798.16
Upgrade
Current Ratio
14.2531.4138.9222.0424.588.76
Upgrade
Return on Equity (ROE)
-62.03%-46.26%-29.72%-30.58%-50.16%-96.73%
Upgrade
Return on Assets (ROA)
-18.95%-10.30%-10.93%-18.30%-22.54%-31.96%
Upgrade
Return on Capital (ROIC)
-19.56%-10.54%-11.31%-19.04%-23.55%-34.42%
Upgrade
Buyback Yield / Dilution
-113.10%-78.47%-2.57%-114.60%-460.40%-31.72%
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q